Gene Testing

Last October, Nanosphere, Inc. (Northbrook, IL) received FDA approval for “the first nanotechnology-based microfluidics product capable of analyzing DNA directly from a blood sample.” It’s name is Verigene.  A test for, say, Coumadin clearance, which could determine a patient’s optimum dosage for this anticoagulant, might be completed in less than two hours in a hospital or a doctor’s office.  Among the more promising applications for this quick pharmacogenomic testing is with medications used in intensive care units.     MORE

Image Credit: Nanosphere and Technology Review